SomaLogic Operating Co., Inc.
Boulder, Colorado, United States
Purpose
to discover biomarkers in blood that can be used to identify individuals at risk of developing active tuberculosis (TB) for priority enrollment into TB vaccine trials
Division
Global Health
Date
February 2014
Region Served
GLOBAL
Committed amount
$430,153
Grant topic
Discovery and Translational Sciences
Duration (months)
47
Grantee location
Boulder, Colorado, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.